Long-term follow-up of trans-obturator vaginal tape for stress urinary incontinence: a single-center retrospective study
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
Among surgical options for stress urinary incontinence, the trans-obturator tape (TOT) procedure is preferred for its effectiveness and safety, but long follow-up data on its outcomes remain limited. This study evaluates the long-term efficacy and safety of the “out-in” TOT procedure using the InGyneS Dipromed device (Dipromed s.r.l, San Mauro T.se, Turin, Italy). A total of 43 patients who underwent the TOT procedure at S. Croce Hospital in Moncalieri between 2011 and 2023 were included. Medical history, pelvic examination, stress test, and urodynamic tests were considered, along with the Patient Global Impression of Improvement scale, a patient satisfaction scale, and the Incontinence-Quality of Life questionnaire. The patients were grouped by follow-up duration: group 1 (<5 years of follow-up) and group 2 (>5 years of follow-up). Objective and subjective cure rates and complications were recorded. The objective cure rate was 62.5% in group 1 and 63.2% in group 2, while the subjective success rates were 83.3% and 73.7%, respectively. Complications were rare and the differences between the two groups were not statistically significant. The “out-in” TOT procedure is effective and well-tolerated, with favorable long-term outcomes and low complication rates.
Ethics Approval
Study approval was granted by the Ethics Committee of S. Croce Hospital (N. 8280 del 19/05/2023) and is subject the ethical standards of the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.How to Cite

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.